FDA Approves A New Class of Lipid-Lowering Drugs - PCSK9 Inhibitors - Ellen Dolgen
Search
Close this search box.

FDA Approves A New Class of Lipid-Lowering Drugs – PCSK9 Inhibitors

Heart Health News!! One out of three American adults is estimated to have high LDL cholesterol, according to the Centers for Disease Control and Prevention. Elevated LDL cholesterol is recognized as a major risk factor for cardiovascular disease, which remains the leading cause of death worldwide.   In the United States, 1 in 4 women dies from heart disease.

The FDA granted marketing approval on Thursday to evolocumab (Repatha), the second in a new class of lipid-lowering drugs — PCSK9 inhibitors. These drugs appear to sharply reduce levels of bad (LDL) cholesterol. Clinical trials of PCSK9 inhibitor drugs developed by Amgen, Sanofi and Regeneron demonstrate LDL levels are reduced by 60%. By comparison, statins — the current class of drugs that are the mainstay of treatment for high LDL — generally reduce LDL levels by 30-50%.

At this point, these new drugs appear to be quite costly.  However, it is always good to know the latest options available so that you and your healthcare professional can develop the best plan of action for your individual heart health needs.

Share:

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Latest Updates

Subscribe To MENOPAUSE MONDAYS® Blog

No spam, notifications only about new products, updates.

Social Media

Categories

On Key

Related Posts

Two women sitting on a couch with a beverage in hand talking and laughing

The Secret to Longevity: The Role of Social Connectedness

Welcome back to Menopause Mondays®! Today, we’re shifting our focus from the menopausal transition to a relevant topic at any stage of life: the importance of social connectedness in promoting longevity. There were several ongoing research studies and findings related to longevity and social connections. It turns out that staying socially engaged can be a

Yellow stethoscope and red heart

Know Your Risks for Heart Disease

Hello, fabulous ladies, and welcome to a special Heart Health Month edition of Menopause Mondays®! Today, we’re diving deep into the topic of heart health and focusing on something vital – knowing your risks for heart disease. While menopause brings its own changes and challenges, understanding and managing these risks can make a world of

Embracing Self-Love During Menopause

Welcome to another Menopause Mondays®, a day dedicated to supporting and empowering women through the challenging yet transformative journey of menopause. In today’s blog, we’re going to delve into a topic that’s essential during this phase of life – self-love. Menopause is a time of change, and learning to love and care for yourself is

Are Women Living Longer Than Men?

Welcome to another edition of Menopause Mondays®. While I typically focus on women’s health during menopause, today, we’re diving into the widening gender gap in life expectancy. Recent data from the National Center for Health Statistics reveals that women in the United States now live an average of 5.8 years longer than men, from a

Scroll to Top

If you want to educate your employees, colleagues, or friends about menopause, look no further!

Share via
Copy link